Socioeconomic cost of AML in Sweden—A population‐based study using multiple nation‐wide registers

Abstract Acute myeloid leukemia (AML) is associated with a high economic and clinical burden. Recently novel therapies have been added to standard treatment regimens. Here, we evaluated the economic impact of AML up until the introduction of these novel therapies. Individual data on 2954 adult patie...

Full description

Bibliographic Details
Main Authors: Emma Hernlund, Josefine Redig, Björn Paulsson, Åsa Rangert Derolf, Martin Höglund, Simona Vertuani, Gunnar Juliusson
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:eJHaem
Subjects:
Online Access:https://doi.org/10.1002/jha2.208